Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shireen Sidhu is active.

Publication


Featured researches published by Shireen Sidhu.


Australasian Journal of Dermatology | 2006

Allopurinol induced generalized eosinophilic pustular folliculitis

Colin G Ooi; Patrick Walker; Shireen Sidhu; Lynette A Gordon; Gillian Marshman

A 71‐year‐old Cambodian man who was commenced on allopurinol for the treatment of gout developed a generalized papulopustular follicular eruption 8 weeks following introduction of the drug. The skin biopsy findings were consistent with that of eosinophilic pustular folliculitis. Resolution of the rash took place during the 8 weeks following cessation of allopurinol and treatment with oral and topical corticosteroids.


Australasian Journal of Dermatology | 2010

Frontal fibrosing alopecia associated with generalized hair loss

Paul Armenores; Kyoko Shirato; Catherine Reid; Shireen Sidhu

We present six cases of frontal fibrosing alopecia, in which generalized hair loss is a feature. Although this variant of lichen planopilaris has been reported clinically in a number of patients, there is very little histological evidence that the condition exists in peripheral sites. We believe this pattern of involvement may be more common than is reported, and have provided histological evidence of lichen planopilaris being present at sites beyond the scalp and eyebrows.


Australasian Journal of Dermatology | 2013

Post-transplant plasmablastic lymphoma of the skin

Catherine L. Black; Erwin Foster-Smith; Ian D. Lewis; Randall J. Faull; Shireen Sidhu

Plasmablastic lymphoma (PBL) is a recently described rare variant of diffuse large B‐cell lymphoma characterised by its aggressive nature and plasmacytic differentiation. It most frequently arises in the oral cavity of human immunodeficiency virus (HIV)‐infected patients. However extra‐oral involvement is becoming increasingly recognised, particularly in HIV‐negative patients. We report a case of PBL presenting as multiple violaceous nodules and plaques on the leg of a HIV‐negative patient, 13‐years post‐renal transplant. To date, 20 cases of PBL presenting in the skin have been reported. We review and compare the clinico‐pathological features of these cases.


Australasian Journal of Dermatology | 2012

Management pathway of skin conditions presenting to an Australian tertiary hospital emergency department

Arabella Wallett; Shireen Sidhu

There have been limited published data on the management pathway of patients presenting to the emergency department with skin conditions. We report the pathway of patients presenting with skin conditions to a large tertiary hospital for 1 year and make recommendations to optimise the available dermatological services.


Australasian Journal of Dermatology | 2017

Azathioprine‐induced Sweet's syndrome: A case series and review of the literature

Ashling McNally; Jan Ibbetson; Shireen Sidhu

We present three patients with azathioprine‐induced Sweets syndrome (AISS) who attended our tertiary institution within a 12‐month period. Established associations exist between Sweets syndrome and some medications; however, to date links to azathioprine are tentative. While there are case reports of AISS, most have occurred in patients with inflammatory bowel disease (IBD), an underlying predisposition for Sweets syndrome. Our case series adds to the evidence that the entity of AISS truly exists independent of confounding factors such as concurrent IBD.


Australasian Journal of Dermatology | 2015

Cutaneous manifestations of peripheral T-cell lymphoma, not otherwise specified: A case series highlighting the diagnostic challenges for this heterogeneous group

Arabella Wallett; Jan Ibbetson; Daniel Kearney; Kate Newland; Shireen Sidhu

Peripheral T‐cell lymphoma, not otherwise specified (PTCL, NOS) is a rare, heterogeneous group of nodal and extranodal mature T‐cell lymphomas that do not correspond to any of the defined T‐cell entities, according to the World Health Organization classification. Most cases present with late stage nodal disease; however extranodal involvement is common. Skin and subcutaneous involvement is reported in approximately 20% of cases. Little attention has been given to the highly variable skin manifestations in the literature. It is our experience that lesions can present in ways other than previously described nodular or tumourous lesions that often ulcerate. We present a case series from a large tertiary institution of seven cases of PTCL, NOS with skin involvement, highlighting the variable presentations and diagnostic challenges for this heterogeneous group.


Australasian Journal of Dermatology | 2014

Circulating plakin autoantibodies in a patient with erythema multiforme major: Are they pathogenic or a manifestation of epitope spreading?

Elizabeth Ellis; Shireen Sidhu

Erythema multiforme is a well‐recognised entity but its pathogenesis remains elusive. Theories hypothesise a cell‐mediated immune pathogenesis, however recent case reports have observed autoantibodies to the plakin family of proteins, suggesting a role for the humoral immune system. We present a case of erythema multiforme major with circulating desmoplakin autoantibodies in a 36‐year old woman who was previously diagnosed with pemphigoid gestationis. The close correlation between the concentration of these autoantibodies and the severity of clinical disease strongly suggests a pathogenic role in her disease. As previous case reports have proposed, these autoantibodies may be directly pathogenic. Alternatively, the epiphenomenon of epitope spreading must be considered in the subset of patients with erythema multiforme major.


Australasian Journal of Dermatology | 2007

A 30-year history of CD4+ vesiculo-bullous mycosis fungoides and multiple visceral malignancies

Annette Pearce; Catherine Reid; Amanda Gramp; Shireen Sidhu

An 83‐year‐old Caucasian woman presented with a 25‐year history of an itchy, eczematous blistering eruption affecting her trunk and acral sites. She had a past history of adenocarcinoma of the lung, colorectal carcinoma and bladder carcinoma. Several skin biopsies consistently showed features of a spongiotic process. Direct and indirect immunofluorescence studies were repeatedly negative, excluding the possibility of an autoimmune blistering disorder. A skin biopsy several years later, however, showed histological and immunophenotypic features of mycosis fungoides. The literature on this rare phenotype of cutaneous T‐cell lymphoma generally portrays a negative prognosis. Our case illustrates an excellent prognosis with stable disease 30 years after onset.


Australasian Journal of Dermatology | 2015

Heavy metal (monoclonal) bands: a link between cutaneous T-cell lymphoma and contact allergy to potassium dichromate, nickel and cobalt?

Dev Tilakaratne; Shireen Sidhu

It has been proposed that chronic antigenic stimulation plays a role in the pathogenesis of cutaneous T‐cell lymphoma (CTCL). By definition, antigenic stimulation triggers allergic contact dermatitis (ACD). It is therefore plausible that chronic ACD could serve as a precursor to CTCL. We report two cases of contact allergy to potassium dichromate, nickel and cobalt, where CTCL was diagnosed in one patient, and a diagnosis of CTCL is imminent in the other. We also review the literature on the diagnostic criteria for CTCL in the setting of ACD and explore potential mechanisms for the progression from ACD tos CTCL.


Australasian Journal of Dermatology | 2014

Mycophenolate mofetil as a treatment for urticarial dermatitis

Cassandra Chaptini; Shireen Sidhu

We report two cases of adults with urticarial dermatitis who could not be managed by a variety of treatments but who obtained good control with mycophenolate mofetil (MMF). A clinical response was seen 6‐8 weeks from treatment onset and they were maintained on MMF 1 g twice daily (case 1), and MMF 1 g omni mane and 500 mg omni nocte (case 2), with no major exacerbations for many years. MMF is an immunosuppressive agent, which is currently used off‐label for many dermatological conditions. To date, there have been no studies investigating the use of MMF as a treatment for urticarial dermatitis. The cases we present suggest that MMF is an effective treatment for this condition, and we recommend that MMF be considered as a treatment option.

Collaboration


Dive into the Shireen Sidhu's collaboration.

Top Co-Authors

Avatar

Jan Ibbetson

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arabella Wallett

Women's and Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Kearney

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Colin G Ooi

Flinders Medical Centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge